2022 U.S. Equities Outlook: Still Favoring the Base Case

2022 U.S. Equities Outlook: Still Favoring the Base Case

Our 2022 outlook presented a wider than normal range of potential paths. While our base case still appears likely, shifts in supply and Fed policy could cause a change in course.


----- Transcript -----

Welcome to Thoughts on the Market. I'm Mike Wilson, Chief Investment Officer and Chief U.S. Equity Strategist for Morgan Stanley. Along with my colleagues bringing you a variety of perspectives, I'll be talking about the latest trends in the financial marketplace. It's Monday, December 13th at 11:30 a.m. in New York. So let's get after it.

In writing our year ahead outlook, we were faced with what we think is a wider than normal range of potential economic and policy outcomes. This higher "uncertainty" was one of the inputs to our key conclusion - that valuations for U.S. equity markets were likely to come down over the next 3-6 months. In our discussions with hundreds of clients since publishing our outlook, the conversations have centered on these three potential outcomes and how to handicap them.

First is Goldilocks. When we published our outlook on November 15th, this was the prevailing view by most clients. In this outcome, supply picks up in Q1 to meet the excess demand companies are having a hard time fulfilling. Inflation has a relatively fast but soft landing towards 2-3%, which allows for growth to remain strong and multiples to remain high. The S&P 500 reaches 5000 by year end 2022. And this was our bull case in our outlook with a 20% probability.

In the second outcome, inflation remains hot and the Fed responds more aggressively. Under this outcome, inflation proves to be stickier as supply chains and labor shortages remain difficult to fix in the short term. The Fed is forced to taper faster and even raise rates on a more aggressive path. This was our base case, as it essentially lined up with our hotter but shorter cycle view we first wrote about back in March. At the same time, operating leverage fades as costs increase more in line with revenues. This leaves market breadth narrow in the near-term as valuations fully normalize in line with the typical mid-cycle transition. While there is some debate around how much P/Es need to fall, we believe 18x is the right number to use for year-end 2022. When combined with 10% earnings growth, that gives us a slight downside to the index from current prices, or 4400 on the S&P 500. We put a 60% probability on this outcome.

The third outcome assumes supply ticks up, but demand fades. Under this scenario, we assume supply comes too late to meet what has been an unsustainable level of consumption for many goods. It's also too expensive for customers who have become wary of higher prices, which leads to demand destruction for many areas of the economy. While services should fare better and keep the economy growing, goods producing companies suffer. Under this scenario, the Fed may back off on their more aggressive tightening path. Rates fall, but not enough to offset the negative impact on margins and earnings, which will end up disappointing. This is essentially the "Ice" part of our Fire and Ice narrative turning out to be chillier. Equity risk premiums soar and multiples fall more than under our base case. This was our bear case with a 20% probability.

Since publishing, we feel more confident about our base case being the most likely outcome. Inflation data continues to come in hot and companies are having little problem passing it along, for now. While this will likely lead to another good quarter of earnings, we suspect there will be more casualties too, as execution risk is increasing. This will leave dispersion high and leadership inconsistent - two more conclusions in our outlook. Stock picking will be difficult, but a necessary condition to generate meaningful returns in 2022 as the market index is flat to down over the next 12 months.

This is a big week on policy outcomes, with the Fed likely to announce a more aggressive timeline for tapering its asset purchases. In short, we expect the Fed to tell us that they will end its asset purchase program by March 31st. While our base case always assumed the Fed would respond appropriately to higher inflation, this is a more aggressive pivot than what we expected a month ago. Importantly, the Fed is now suggesting stable prices are important to achieving its primary goal of full employment, which means inflation is taking center stage until it's under control. Finally, we think Jay Powell and the Fed will be under much less pressure from the White House versus the last time they were aggressively removing monetary accommodation in late 2018. Part of this is due to the fact that inflation is a much bigger problem today than it was in 2018, and part of it is due to the observation that the White House today is not as preoccupied with the stock market. Bottom line, the Fed is determined to bring down inflation, and falling stock prices are unlikely to stop them from trying.

In this kind of an environment, we continue to favor companies with earnings stability and reasonable valuations. That means large cap defensive quality stocks. In short, boring can be beautiful.

Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

Jaksot(1554)

Why Shutdown Standoff Raises Stakes for Healthcare

Why Shutdown Standoff Raises Stakes for Healthcare

Our analysts Ariana Salvatore and Erin Wright explain the pivotal role of healthcare in negotiations to end the government shutdown.Read more insights from Morgan Stanley.----- Transcript -----Ariana ...

30 Loka 20255min

M&A Poised to Gain Momentum

M&A Poised to Gain Momentum

Our Head of Corporate Credit Research Andrew Sheets explains why the recent revival of M&A activity has room to accelerate.Read more insights from Morgan Stanley.----- Transcript -----Andrew Sheets: W...

29 Loka 20254min

A Turnaround in Sight for Healthcare?

A Turnaround in Sight for Healthcare?

Our U.S. Biotech and Biopharma analysts Sean Laaman and Terence Flynn discuss the latest developments that could be positioning the healthcare sector for strong outperformance.Read more insights from ...

28 Loka 20255min

Will the Stock Market Rally Continue?

Will the Stock Market Rally Continue?

Our CIO and Chief U.S. Equity Strategist Mike Wilson discusses the outlook for stocks after the preliminary U.S.-China trade agreement and ahead of the Fed meeting and big tech earnings.Read more insi...

27 Loka 20253min

What Happens to Software Developers as AI Can Code?

What Happens to Software Developers as AI Can Code?

Our U.S. Software Analyst Sanjit Singh explains how AI is reshaping software development and why the future for the sector may be brighter – and busier – than ever.Read more insights from Morgan Stanl...

24 Loka 20254min

Should AI Spending Worry Investors?

Should AI Spending Worry Investors?

Our Head of Corporate Credit Research Andrew Sheets wades into the debate around whether the boom in artificial intelligence investment is a warning sign for credit markets. Read more insights from Mo...

23 Loka 20253min

The Next Turning Points in Tech

The Next Turning Points in Tech

Our analysts Brian Nowak, Keith Weiss and Matt Bombassei break down the most important tech insights from Morgan Stanley’s Spark Private Company Conference and industry shifts that will likely shape 2...

22 Loka 202511min

How to Navigate U.S.-China Tensions

How to Navigate U.S.-China Tensions

Our Global Head of Fixed Income Research and Public Policy Michael Zezas discuss the latest developments in U.S.-China relations and how they could affect investors.Read more insights from Morgan Stan...

21 Loka 20253min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
ostan-asuntoja-podcast
herrasmieshakkerit
rss-rahamania
rahapuhetta
rss-h-asselmoilanen
rss-seuraava-potilas
rss-paasipodi
inderespodi
taloudellinen-mielenrauha
rss-neuvottelija-sami-miettinen
rss-markkinointitrippi
van-elamaa
pomojen-suusta
sijoituspodi
yrittaja
rss-lahtijat